Corvus Pharmaceuticals, Inc.
CRVSAs of the close on Sep 25, 2026
Price
$11.62
Market cap
$977M
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Corvus Pharmaceuticals, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 11 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 15, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Truvestments Capital LLC | 2026-03-31 | 10,257 | $150K | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 44,473 | $651K | SEC filing |
| ALLIANCEBERNSTEIN L.P. | 2026-03-31 | 61,740 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 9,362 | $137K | SEC filing |
| JACKSON SQUARE CAPITAL, LLC | 2026-03-31 | 63,773 | $933K | SEC filing |
| Virtus Investment Advisers, LLC | 2026-03-31 | 32,579 | $477K | SEC filing |
| Optimize Financial Inc | 2026-03-31 | 28,060 | $411K | SEC filing |
| TOWERVIEW LLC | 2026-03-31 | 70,000 | $1.02M | SEC filing |
| Blue Owl Capital Holdings LP | 2026-03-31 | 545,000 | $7.97M | SEC filing |
| WELLINGTON MANAGEMENT GROUP LLP | 2026-03-31 | 2,318,517 | $33.9M | SEC filing |
| Tema ETFs LLC | 2026-03-31 | 107,775 | $1.58M | SEC filing |
| SEI INVESTMENTS CO | 2026-03-31 | 60,848 | $890K | SEC filing |
| Vivo Capital, LLC | 2026-03-31 | 2,805,816 | $41M | SEC filing |
| SEVEN GRAND MANAGERS, LLC | 2026-03-31 | 50,000 | $732K | SEC filing |
| INTECH INVESTMENT MANAGEMENT LLC | 2026-03-31 | 23,381 | $342K | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 866,362 | $12.7M | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 6,160,422 | $90.1M | SEC filing |
| Creative Planning | 2026-03-31 | 43,032 | $630K | SEC filing |
| DIADEMA PARTNERS LP | 2026-03-31 | 244,811 | $3.58M | SEC filing |
| DRW Securities, LLC | 2026-03-31 | 10,584 | $155K | SEC filing |
- Each value is checked against Corvus Pharmaceuticals, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Corvus Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-05-06 · MILLER RICHARD A MD: Larger than all 29 other insider purchases of Common Stock on file. SEC filing
- 2022-12-13 · MILLER RICHARD A MD: Larger than 27 of the 29 other insider purchases of Common Stock on file. SEC filing
- 2021-02-17 · ORBIMED ADVISORS LLC: Larger than 41 of the 42 other insider purchases of Common Stock, $0.0001 par value on file. SEC filing
- 2021-02-17 · MILLER RICHARD A MD: Larger than 28 of the 29 other insider purchases of Common Stock on file. SEC filing
- 2021-02-17 · Thompson Peter A.: Larger than 41 of the 42 other insider purchases of Common Stock, $0.0001 par value on file. SEC filing
- 2018-03-12 · Thompson Peter A.: Larger than 39 of the 42 other insider purchases of Common Stock, $0.0001 par value on file. SEC filing
- 2018-03-12 · ORBIMED ADVISORS LLC: Larger than 39 of the 42 other insider purchases of Common Stock, $0.0001 par value on file. SEC filing
Independent insiders buying near the same time
- 2024-05-06–2024-05-06: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2024-05-06–2024-05-06: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2024-05-06–2024-05-06: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2024-05-06–2024-05-06: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2022-12-13–2022-12-20: 5 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2022-03-15–2022-03-17: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2021-02-17–2021-02-17: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2019-08-06–2019-08-07: 4 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2019-06-27–2019-07-01: 6 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2019-06-07–2019-06-14: 5 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2019-06-06–2019-06-13: 5 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2018-12-20–2018-12-27: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2018-03-12–2018-03-12: 13 event(s) across 5 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-11 | Moore David Scott · Director | Common Stock | P — Open market or private purchase | +21,700 | 11.53 | SEC filing |
| 2026-05-18 | MILLER RICHARD A MD · President and CEO | Common Stock | P — Open market or private purchase | +1,932 | 12.01 | SEC filing |
| 2026-05-18 | MILLER RICHARD A MD · President and CEO | Common Stock | P — Open market or private purchase | +5,000 | 12.05 | SEC filing |
| 2025-06-27 | Thompson Peter A. · Director, 10% owner | Common Stock | S — Open market or private sale | −1,176,332 | 4.16 | SEC filing |
| 2025-06-27 | ORBIMED ADVISORS LLC · Director, 10% owner | Common Stock | S — Open market or private sale | −1,176,332 | 4.16 | SEC filing |
| 2024-05-06 | MILLER RICHARD A MD · President and CEO | Common Stock | P — Open market or private purchase | +577,634 | 1.73 | SEC filing |
| 2024-05-06 | Thompson Peter A. · Director, 10% owner | Pre-Funded Warrants (right to buy) | P — Open market or private purchase | +1,444,085 | 1.73 | SEC filing |
| 2024-05-06 | Thompson Peter A. · Director, 10% owner | Common Warrants (right to buy) | P — Open market or private purchase | +1,397,684 | unknown | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-11 | Thompson Peter A. · Director, 10% owner | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-11 | CLARK IAN T · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-11 | van den Broek Richard · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-11 | Grais Linda · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-11 | Moore David Scott · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-04-23 | Chan Andrew C. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-01-28 | Thompson Peter A. · Director, 10% owner | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −15,000 | SEC filing |
| 2026-01-28 | Thompson Peter A. · Director, 10% owner | Common Stock | M — Exercise or conversion of derivative security | +15,000 | SEC filing |
Showing 8 of 22 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.